The Future Of Gene Therapy Production: Enriching Full Capsids, Reducing Costs

Developing Your Risk-Based Approach To Single-Use System Integrity

Optimize DNA Clearance In High-Salt, GMP-Grade Purification Processes

The Case For Optimized And Excipient GMP Cell Culture Solutions

Enhancing Non-Viral CAR T Manufacturing With Electroporation And Microbubble T Cell Isolation

Unlocking Allogeneic Cell Therapy: Exploring Durable Approaches

In-Line PAT Solutions For cGMP Environments

Development Of An Off-The-Shelf γδ T-Cell Platform

From Plasmids To Cell-Free DNA Using Megabulb DNA

Break The Cell Therapy Manufacturing Bottleneck With Day-0 Transduction, Day-3 Harvest

Evolving Gene Editing For Rare Disease Drug Development

Cell Bank And Scale Up Strategies For MSC And Exosome Manufacturing

Using ddPCR Technology To Characterize The Poly(A) Tail Content

LC/MS Method For Measurement In Human Plasma

Can You Run Crude Samples Using An SPR Instrument?

Early-Phase Whole-Body PK

Is Evaporation Important For Optical Biosensors?

Validation Of An LCMS Hybrid Assay With EVOSEP Cleanup

A Derivatization-Free LCMS Assay For 4β-hydroxycholesterol

Analytics & Assays: Defining mRNA Therapeutic Impurities Early & Often

Is The Sensitivity Of Optical Biosensors Important?

LC/MS/MS Analysis Of Coproporphyrin 1, Coproporphyrin 3 In Human Plasma

Elucidating The Role Of IL-18 In NSCLC Integrated Analysis

Advancing Allogeneic Cell Therapy for SCI and Blindness with Lineage's Brian Culley

How AI and ML Drive iPSC Quality with Aspen Neuroscience's Thorsten Gorba, Ph.D.

Inside Sanofi's Genomic Medicine Vision with Mike Quigley, Ph.D.

Engineering Off-The-Shelf Cell Therapies For Cancer And Autoimmune Disease With Ernexa Therapeutics' Sanjeev Luther

What Changes to FDA and CBER Mean for the Future of CGT with Daniela Drago

Inside CRISPR-GPT With Yuanhao Qu

Barriers, Breakthroughs, and Building Access in Pediatric CGTs with Bambi Grilley, Ph.D.

Defining Product Roles and Navigating FDA Approval with Monika Swietlicka

Advancing Gene Therapy for FTD with Passage Bio's Dr. Will Chou

FDA Fridays: Advancing Communication and Consistency in CGT Regulation with Kaye Spratt

Navigating The Journey To Safer Stem Cell Therapies With Orca Bio's Nate Fernhoff

Rethinking Large Animal Models in Gene Therapy with Novartis' Ralf Schmid, Ph.D.

SF-RVN® Platform For Improving The Safety Profile Of Your Therapies

Manufacturing Life-Saving Gene Therapies

LC/MS Method For Measurement In Human Plasma

A Transformative Journey From Research To Large-Scale Production

Mycap® CCX Cell Culture Expansion System

Freezing Studies For Single-Use Solutions: Long-Term (Part 2)

Challenges Of The IVT Reaction In mRNA Production

How Biologic Therapeutics Are Developed

MicroCNX Series Connectors Assembly Overview

How To Maintain A Nuclease Free Environment During mRNA Production

How MilliporeSigma Promotes Quality And Risk Reduction

Supporting Biopharma Manufacturing With Freezing Study Capabilities

Early-Phase Whole-Body PK

What Is Causing Limited Bioavailability

Minaris Advanced Therapies Philadelphia Campus Overview

Get To Know Minaris Advanced Therapies Testing Services

Biopharma Resilience: Bionova Scientific Talks Capacity, Speed, And Agility

Closing Ancillary Processes: The New Bottleneck In Cell and Gene Therapy

Selecting The Right CMO For Your Gene Therapy

Supporting The Global Biopharma Industry With Single-Use Capacity Expansion

Robust And Consistent Frozen Storage And Shipment

Microcarrier Separation Systems

Storing Your Banks With Ease And Confidence

A Dedicated Team To Safely Store Your Cell And Virus Banks

Accelerate Innovation With Compliant Software Solutions

Visual Inspection Of Advanced Therapy Medicinal Products

Boost Compliance And Efficiency With Real-Time Asset Management

Ensuring The Safety Of Cell Therapy Manufacturing Through Quality Control Solutions

Is Your Current AAV Process Holding You Back?

PEI And Non-PEI Transfection Solutions For High Titers And Production

CellShot PFEP™ + Proliva™: Enhancing Post-EP Proliferation

How CRISPR And LNP Accelerate Therapeutic Innovation Through Analytics

Addressing Core Requirements In CGT Manufacturing Optimization

Navigating Challenging Cell Engineering Workflows With A Scalable, Proven Electroporation Platform

Non-Viral Delivery Of Complex Cargos For Large-Scale T-Cell Manufacturing

Accelerate Manufacturing With GMP-Compliant Automation Solutions

Designing Early Manufacturing For Long-Term Success In CGT

Building The Future Of Cancer Immunotherapy Through Allogeneic NK Cell Innovation

Redefining CGT With Exosomes And EVs

Advancing Gene Delivery: LNPs, Adenovirus, Lentivirus, And More

Unlocking The Potential Of iPSC Therapies In Regenerative Medicine

Emerging Manufacturing Technologies For Cell Therapies

Optimizing Storage Solutions For Allogeneic iPSCs

2025 CGT Regulatory Outlook

Unlocking The Full Potential Of AAV-Mediated Gene Delivery

Inside The Most Promising Non-Viral Approaches For Genetic Engineering

From Bottleneck To Breakthrough: Reimagining The mRNA Therapeutics Supply Chain

Modernizing CAR-T Manufacturing: Is Point Of Care The Future?

Top Strategies To Reduce Off-Target Effects For Safer Genome Editing

Inside Next-Gen Platforms For Cell Therapy Manufacturing

Unlocking The Future Of Allogeneic Cell Therapy For Oncology

Stem-Cell Derived Therapies: From Source To Site

How To Reduce Batch-to-Batch Variation In Cell Therapy Manufacturing

2024 Regulatory Outlook With FDA's Drs. Peter Marks And Nicole Verdun

Considerations For Investing In Your Gene Therapy's Automation Framework

mRNA For Cancer Immunotherapy: 2024 Outlook

Are We There Yet? Roadmap(s) To Higher Quality AAV

Optimizing Your Cold Chain For Cell Therapies

Stability To Scalability: The Future Of Viral Vector Therapies

Regulating The CGT Workflow To Improve Patient Safety

Driving Down COGS: Automation's Role In Cell Therapy Manufacturing

Major Trends In Next-Gen RNA Engineering

Building An In-House Cell & Gene Manufacturing Facility: Best Practices & Lessons Learned

Scaling Cell Therapies Part 2: Establishing Comparability In Manufacturing

Tackling Cell And Gene Therapies' Top 3 Regulatory Impediments

Evaluating Translational Research Tools For CGTs

Scaling Cell Therapies: Auto vs. Allo

Advancements In Targeted mRNA Delivery

Win The CGT Talent Fight: How To Find And Retain Experts

Kite Pharma's Ultimate Supply Chain Test - A Q&A With Their 4-Exec Panel On Overcoming The Pandemic's Disruption

The Therapeutic Potential Of Exosomes

The Future of CRISPR-Engineered Stem Cell Therapies

Strategies To Reduce Regulatory Risks In Gene Therapy

Lower Variability For Viral Titer Determination

Simplifying Bioprocess Data Collection

Executive Roundtable: Cell Therapy Predictions For 2025 And Beyond

Emerging From Stealth With Vima Therapeutics' Bernard Ravina, M.D.

BoB in South Florida: Rich Daly, Catalyst Pharmaceuticals

BoB In South Florida: Anthony Japour, M.D., iTolerance

BoB In South Florida: Daniel Teper, NAYA Therapeutics

BoB In South Florida: Raquel Cabo, Miami Biotech Collective

The Business Case For Health Economics And Outcomes Research With ISPOR's Rob Abbott

Cannabinoid And Psychedelic Combinations With Incannex Healthcare's Joel Latham

Dye Drug Conjugates For Cancer With Lahjavida's Lyle Small

Investing In The Biostack With Modi Ventures' Sahir Ali, Ph.D.

Improving Cardiovascular Outcomes With Immediate Therapeutics' Atul Deshpande, Ph.D.

Building A Biotech Incubator And Accelerator With Swiss Rockets Founder And CEO Vladimir Cmiljanovic, Ph.D.

Biotech Product Partnership with Coya Therapeutics' Arun Swaminathan, Ph.D. and Dr. Reddy's Milan Kalawadia

Navigating The Complexity of Conditionally Active Biologics With Bonum Therapeutics' Diane Hollenbaugh, Ph.D., and Neela Patel, Ph.D.

Developing Antibodies To Block Neuroinflammation With MindImmune's Stevin Zorn, Ph.D.

Engineering Bacterial Vector-Based Immunotherapies With OS Therapies' Paul Romness and Robert Petit, Ph.D.

How J&J Is Tackling Alzheimer's Disease With Fiona Elwood, Ph.D.

CDMO Hunger Games And The State Of Biotech With Siren Biotechnology's Nicole Paulk, Ph.D.

Delivering Biologics To The Brain With Adaptin Bio's Michael Roberts, Ph.D., and Duke University's Mustafa Khasraw, MD

Developing An In Vivo CAR-T With Interius BioTherapeutics' Sianny Christanti and Babu Medi, Ph.D.

Functional Antibody Screening With Abalone Bio's Richard Yu, Ph.D.

Using Algae To Manufacture Oral Biologics With Lumen Bioscience's Craig Behnke, Ph.D.

PILOT: Introducing Better Biopharma